Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

Accessed on 12 May 2015 from http://www.synthon.com/Corporate/News/PressReleases/Synthon-Announces-Successful-Outcomes-from-the-Open-label-extension-of-the-GATE-Study?sc_lang=en.